Home medical devices pose risks for Medicare beneficiaries and their caregivers
Home medical devices offer health assistance but present potential safety issues and lack comprehensive support for users.
Ozempic and Wegovy should be covered by Medicare as weight loss treatments: KFF poll
GLP-1 drugs used for diabetes and heart disease gaining popularity as weight loss treatments.
KFF survey shows limited usage of GLP-1 drugs for weight loss, with interest in Medicare coverage for weight loss drugs.
COVID and Medicare payments spark remote patient monitoring boom
Remote monitoring services are increasingly being recommended by doctors to keep tabs on patients with chronic illnesses, particularly amid the COVID-19 pandemic.
Medicare made it easier for doctors to bill for monitoring routine vital signs since 2019, allowing for broader coverage and payment flexibility.